InvestorsHub Logo
icon url

lucky, mydog

06/27/15 12:49 PM

#59817 RE: Mind_Sinker #59816

In particular, there are questions regarding the accuracy and completeness of REVO's
public assertions relating to, among other things: (1) REVO's license of certain patents to
Eyetalk365, LLC ("Eyetalk"), including a $900,000 "in consideration" fee paid by Eyetalk to
REVO and related net income received by REVO; (2) a line of credit of up to $10 million obtained
by REVO's wholly-owned subsidiary, Greenwood Finance Group, LLC ("Greenwood");
(3) Greenwood's ownership of $7 million of promissory notes, and interest payments made to
Greenwood in connection with such promissory notes with a projected possible cash value
exceeding $1 million; and (4) REVO's possible plans to issue dividends and buy back shares of its
2
common stock. In addition, REVO currently is delinquent in filing its Form 10-K annual report
for its fiscal year ended December 31, 2014, and its Form 10-Q quarterly report for its first quarter
ended March 31, 2015.